ArticleFrontiers in oncology2022

Case report: Almonertinib in combination with bevacizumab for leptomeningeal metastases from epidermal growth factor receptor-mutation non-small cell lung cancer: Case series.

Yuhai Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.